ITC DIA Europe

Infermedica: AI-driven preliminary diagnosis and triage tools

Written by Roger Peverelli and Reggy de Feniks - Founders The DIA Community on Jul 30, 2020

Infermedica provides insurance companies and health systems with a set of advanced, AI-driven decision support and triage tools that tackle the problem of inappropriate use of medical services and misdiagnosis. With the help of Infermedica’s products: Symptom Checker, Call Center Triage and Medical API, it is easier than ever to connect patients with the right medical services that improve customers’ performance, increase healthcare accessibility, and reduce costs.

Infermedica’s diagnosis engine is a powerful solution that uses artificial intelligence to find correct and cost-efficient care for the patients served. The AI suggests the most suitable and cost-efficient action to take such as visiting or calling a doctor, self-care treatment or going to an Emergency Department in case of highly severe symptoms. Infermedica assists patients in making the best decisions regarding their symptoms and allows healthcare companies to save money by making sure that patients use the proper services to treat their health issues.

Key benefits:

  • Minimize over and under-triage
  • Prevent unnecessary visits
  • Convert face-to-face visits to teleconsultations
  • Standardize the interview process
  • Facilitate the documentation process (EHR integration)
  • Optimize patient flow

 The technology helps companies find out what kind of care their patient needs. They will know exactly who can stay home, who qualifies for teleconsultation, who should see a doctor or who needs urgent medical care. Accurate triage results allow connecting patients to appropriate medical or insurance services.

How it works


The strength of Infermedica’s symptom checker is how it works with organizations’ existing software and processes.

Why we selected Infermedica for DIA Amsterdam
Infermedica creates AI-driven solutions that helps insurance, healthcare and telemedicine companies increase efficiency, improve patient flow, and reduce costs. The company is continually pushing forward the development of their medical database covering nearly 700 conditions and 1300 symptoms. In the upcoming months, they will also release the pediatric content, that will let them guide younger patients to the right care.
Their solutions are now available in 17 languages.

Who is Infermedica?
Infermedica is a health IT company launched in 2012. They are a cross-disciplinary team of over 70 doctors, data scientists and software engineers passionate about the potential of AI in preliminary medical diagnosis. The company is led by an expert team with a track record of leadership in clinical trials, IBM Watson project delivery and AI. The company is based in Wrocław, Poland but operates globally with a rapidly growing market presence in Europe, North America, Asia, and the Middle East. They are backed by Karma Ventures, Dreamit Ventures, Inovo Venture Partners and Müller Medien.

We want to make healthcare a more accessible and safer space for both patients and medical professionals by developing the most advanced AI-driven diagnostic tool”. Piotr Orzechowski, CEO Infermedica

Amsterdam 12-13 June


00 Days
00 Hours
00 Minutes
00 Seconds
Have a look!
ITC DIA Europe - Amsterdam 2024 - Register here! Purchase now!